AKI603 is a novel small molecule inhibitor of Aurora kinase A (AurA)(IC50 = 12.3 nM). AKI603 is developed to overcome resistance mediated by BCR-ABL-T315I mutation. AKI603 exhibits strong anti-proliferative activity in leukemic cells[1][2].
Molecular Weight:
409.45
Purity:
99.81%
CAS Number:
[1432515-73-5]
Formula:
C19H23N9O2
Target:
Aurora Kinase
T64338
* VAT and and shipping costs not included. Errors and price changes excepted